E

Endo International PLC
LSE:0Y5F

Watchlist Manager
Endo International PLC
LSE:0Y5F
Watchlist
Price: 695.3 USD 2.4% Market Closed
Market Cap: 156B USD
Section:
Wall Street Price Targets
Wall Street Price Targets
Revenue Forecast
Operating Income Forecast
Net Income Forecast
See Also
Price Target
Loading...
Revenue
Loading...
Operating Income
Loading...
Net Income
Loading...

Wall Street
Price Targets

0Y5F Price Targets Summary
Endo International PLC

There are no price targets for 0Y5F.
0Y5F Lowest Forecast
Wall Street Target
Not Available
0Y5F Average Forecast
Wall Street Target
Not Available
0Y5F Highest Forecast
Wall Street Target
Not Available
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
Endo International PLC Competitors:
Price Targets
N
603707
Nanjing King-friend Biochemical Pharmaceutical Co Ltd
82% Upside
4528
Ono Pharmaceutical Co Ltd
28% Upside
ARVN
Arvinas Inc
209% Upside
S
4507
Shionogi & Co Ltd
11% Upside
N
603707
Nanjing King-friend Biochemical Pharmaceutical Co Ltd
82% Upside
4528
Ono Pharmaceutical Co Ltd
28% Upside
ARVN
Arvinas Inc
209% Upside
S
4507
Shionogi & Co Ltd
11% Upside
H
1J5
Hyphens Pharma International Ltd
21% Upside
WEED
Canopy Growth Corp
54% Upside
1477
Ocumension Therapeutics
2% Upside
VETO
Vetoquinol SA
28% Upside

Revenue
Forecast

Revenue Estimate
Endo International PLC

For the last 1 year the compound annual growth rate for Endo International PLC's revenue is -23%. The projected CAGR for the next 1 year is -4%.

-23%
Past Growth
-4%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Endo International PLC

Operating Income forecast
is not available for
Endo International PLC

Net Income
Forecast

Net Income Estimate
Endo International PLC

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
What are analyst estimates?

See Also

Summary
0Y5F intrinsic value, competitors valuation, and company profile.
DCF Valuation
0Y5F stock valuation using Discount Cash Flow valuation method.
Relative Valuation
0Y5F stock valuation using valuation multiples.
Wall Street Estimates
0Y5F price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
0Y5F stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is 0Y5F's stock price target?
Not Available

0Y5F doesn't have any price targets made by Wall Street professionals.

What is Endo International PLC's Revenue forecast?
Projected CAGR
-4%

For the last 1 year the compound annual growth rate for Endo International PLC's revenue is -23%. The projected CAGR for the next 1 year is -4%.

Back to Top
ALPHA SPREAD
Follow us
Join more than 257,600+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.